Lineage Cell Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The company's pipeline consists of seven allogeneic cell transplant therapy programs spanning clinical to research stages, targeting a range of conditions including dry-AMD, spinal cord injuries, auditory neuropathy, Type 1 Diabetes, and vision loss, with several programs supported by strategic partnerships with Roche, Genentech, William Demant Invest, and Factor Biosciences.
LCTX Key Statistics
Stock Snapshot
With a market cap of 263.02M, Lineage Cell Therapeutics(LCTX) trades at $1.04. The stock has a price-to-earnings ratio of -5.48.
On 2026-11-04, Lineage Cell Therapeutics(LCTX) stock moved within a range of $1.00 to $1.07. With shares now at $1.04, the stock is trading +4.0% above its intraday low and -2.3% below the session's peak.
Trading activity shows a volume of 539.97K, compared to an average daily volume of 1.26M.
The stock's 52-week range extends from a low of $0.88 to a high of $1.99.
The stock's 52-week range extends from a low of $0.88 to a high of $1.99.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.